Home » Posts tagged 'ian mclellan'

Tag Archives: ian mclellan

Feedback (FDBK) subsidiary CCI signs exclusive agreement with Boya Digital Technology (Beijing) to distribute TexRAD in China

FBKlogoFeedback plc is pleased to announce that its subsidiary, Cambridge Computed Imaging Ltd, has signed an exclusive distributor agreement with Boya Digital Technology (Beijing) Co. Ltd., based in Beijing, China, for sales and distribution of its TexRAD® texture analysis research software in the People’s Republic of China. Boya is an approved vendor to GE Healthcare China, Beijing and is facilitating the purchase and installation process of TexRAD research software on behalf of GE in the PRC.

TexRAD will be used by customers for research purposes, performing advanced analysis of routinely acquired medical diagnostic images (e.g. CT, MRI). As in western countries, university hospitals and research institutions in China are increasingly using innovative software such as TexRAD to generate new knowledge and insights in the fight against cancer and other diseases. The Agreement ensures user access and customer support for TexRAD within the rapidly growing market for medical research in the PRC.

Feedback regards the completion of this Agreement as a significant step in the continuing development of its global sales and market presence as outlined in recent investor presentations.

Dr Balaji Ganeshan, CEO of TexRAD Ltd and Director of New Business at Feedback Plc said; “We are delighted to have formalised the business relationship with both Boya and GE. This follows discussions at the Beijing Society of Radiology in 2016 and involvement in the installation of TexRAD software in a leading medical institution, Peking Union Medical College Hospital, Beijing. I look forward to working with Boya and GE to develop awareness of the capabilities of TexRAD and sales to the medical research community in China.”

Ian McLellan, Commercial Director CCI Ltd commented; “The signing of this Agreement with Boya represents an excellent basis on which to develop our sales and presence in this exciting growth market using the expertise and customer reach of Boya Digital Technologies. We look forward to developing the TexRAD revenue potential and increasing the market reach to our users.”

Ni Xiaowei, President Boya Digital Technologies confirmed; “We are pleased with the addition of TexRAD to our software portfolio, and look forward to working with CCI to promote this texture analysis software to research institutes in leading hospitals within the People’s Republic of China. I anticipate a very successful business relationship, working closely with Dr Balaji Ganeshan and CCI. Boya Digital Technologies has developed a strong reputation for IT sales and support with our customers which we can offer to support the development of TexRAD sales in China.”

Feedback plc
Alastair Riddell

Tel: 01954 718072

Allenby Capital Limited (Nominated Adviser and Joint Broker)
David Worlidge / James Thomas

Tel: 020 3328 5656

Northland Capital Partners Ltd (Joint Broker)
Patrick Claridge / Margarita Mitropoulou

Tel: 020 3861 6625

Peterhouse Corporate Finance Ltd (Joint Broker)
Lucy Williams / Duncan Vasey

Tel: 020 7469 0936

Brand Communications
Alan Green

Tel: 07976 431608

About CCI

CCI Ltd is owned by AIM listed Feedback Plc (FDBK), based in Bourn, Cambridge UK. CCI focusses on the development and supply of advanced software including TexRAD, for texture analysis of medical images and storage and interpretation of imaging data.

About Boya

Boya Digital Technologies, founded in 2004 is based in Beijing, China and has been a manufacturer and supplier of computers, peripherals and software for over 10 years. It is a re-seller and vendor to a number of companies in China. Boya is part of the larger corporate organization, Boya Software Co Ltd, which aims to create value for its customers through technology and services.

About TexRAD

TexRAD is a highly advanced, patented image texture analysis software tool that analyses the textures in routinely acquired diagnostic medical images (e.g. CT, MRI) to reveal features that are not always evident to the human eye. The platform also comprises a novel data-mining tool to assist the research customer to undertake statistical analysis to identify interesting parameters demonstrating association with patient outcome and clinical parameters. A number of research studies published in numerous peer-reviewed journals and conference presentations show that TexRAD texture metrics may have the potential to predict prognosis, disease severity and treatment prediction/evaluation in a number of cancer applications. TexRAD is manufactured under licence by the ISO 13485 certified company Cambridge Computed Imaging Ltd, a subsidiary of Feedback plc.

 

Commercial Director appointed for CCI Ltd – Feedback (FDBK)

Feedback plc are pleased to welcome Ian McLellan as Commercial Director for CCI Ltd. This new role will develop the market and sales channels for our products, supporting sales growth including the launch of next generation TexRAD products as part our commitment to invest in our Brands.

Ian has joined CCI after working closely with the management team over the last six months in a consultancy role to develop our strategy and Commercial structure.

Experienced in both global Corporate and small company environments as well as the NHS, he brings international sales and strategic marketing expertise in nuclear medicine and imaging modalities acquired from GE Healthcare, where he had senior roles in market development and as UK Marketing Manager. Ian also brings a track record of successful licensing and distribution agreements to support our business growth, having in-licensed two ground-breaking nuclear imaging agents whilst at Amersham Healthcare.

His career has involved interaction with stakeholders and users at all levels and this appointment will provide significant additional resource and expertise as CCI seek relationships, local distributors and a widening customer base.

Ian McLellan commentedI have been impressed with the technology and expertise within CCI, and I am pleased to be joining at this exciting time in the Company history as we develop new growth opportunities through product innovation and wider sales channels.

CCI Ltd CEO Mike Hayball observedWe welcome Ian to the management team. He has brought significant expertise to our strategy development and his experience of developing new markets and product launches will enhance our ability to generate growth and strengthen user awareness of our technology.

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.